This page shows the latest RedHill Biopharma news and features for those working in and with pharma, biotech and healthcare.
RedHill Biopharma has announced that its experimental sphingosine kinase-2 (SK2) opaganib demonstrated potent inhibition of SARS-CoV-2 in an in vitro clinical test. ... benefit COVID-19 patients by inhibiting the key drivers of disease progression -
Submits clinical trial applications in Mexico and Brazil. Israeli biopharmaceutical company RedHill Biopharma has announced that it has accelerated its COVID-19 programme with the submission of new clinical trial applications ... Last month, RedHill
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
No results were found
Accession was a born from a passion and a vision. A passion to harness the power of market access to...